Mefloquine Hydrochloride

盐酸甲氟喹

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameMefloquine Hydrochloride
Drug Alias NameLariacur美化喹宁mefloquina甲氟喹宁Larim +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA demethylase ALKBH5 inhibitors
TargetsRNA demethylase ALKBH5
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HIV InfectionsMalaria +[4] 
Global Approved IndicationsMalaria
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1989/05/02
Country/TerritoryBeninUnited StatesItaly +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesWalter Reed Army Institute
China Registration ClassN/A

Develop Information

Active CompaniesHelwan University
Inactive CompaniesInstitut De Recherche Pour Le DeveloppementBiogen IncF. Hoffmann-La Roche Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsHIV InfectionsMalariaLeukoencephalopathy, Progressive Multifocal

Other Information

ATC CodeP01BC02
Related LinksWikipediaDrugBankKEGG